How states are using the law to bring drug executives to heel
Lawyers and regulators are starting to get tough legally to bring generic drug executives to heel, as evidenced by two federal court lawsuits.
Prescription drug market could hit $1.5 trillion by 2021
The QuintilesIMS Institute has released a timely report on the global market for medicines, forecasting a slowdown in drug price increases but overall growth to a massive $1.5 trillion by 2021.
presented by
Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Now, the gloves are off in the EpiPen saga
The maker of EpiPen, the life-saving auto-injector for anaphylaxis, is under fire for exorbitant price hikes so much so that even Martin Shkreli called Mylan out for price-gouging last week.